MORE►
Nanoscope Therapeutics
[Image: istockphoto]
The Last Word: Tech FW on How Nanoscope’s ‘Watch Us’ Moment Could Help Blind Patients See Again
by Quincy Preston | Jul 15, 2025
North Texas' Nanoscope just filed an FDA bid for its gene-agnostic therapy. If approved, it could help restore sight for people with inherited blindness, and potentially millions more with other retinal diseases.
by Lance Murray |
Dec 6, 2024
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
MORE►
by Lance Murray |
Oct 27, 2023
Najam Sharif, Ph.D., DSc, has been appointed as vice president of global research and development by Dallas-based Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.
Sharif is a veteran in drug/device discovery and development, the company said.
“We are delighted to welcome Naj to the Nanoscope team,” Sulagna Bhattacharya, co-founder and CEO of Nanoscope, said in a statement....
MORE►
by Dallas Innovates | Staff Report |
Apr 4, 2023
Dr. Zajicek and three other local biotech leaders—Sulagna Bhattacharya, CEO of Nanoscope Therapeutics; Gabby Everett, director of business operations and strategy at BioLabs Pegasus Park; and R.A. Session II, founder of Taysha Gene Therapies—discussed Dallas' biotech boom on a panel hosted by D CEO Healthcare.
MORE►
Disruptors and Visionaries: The Startups of Dallas-Fort Worth’s Future 50 for 2023
by Quincy Preston | Mar 16, 2023
Meet the startup innovators who are driving change in their industries and beyond. These startups are among the Future 50 in Dallas-Fort Worth, our editors’ picks of forward-thinking innovators who are shaping their industries and communities.
From the healthcare sector to the real estate industry, these trailblazers are disrupting the status quo with their groundbreaking technologies and solutions....
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 11, 2023
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
MORE►
by Lance Murray |
Nov 11, 2022
Dallas-based Nanoscope Therapeutics is developing therapies that could restore sight in patients. The company also recently announced a new gene therapy manufacturing partnership.
MORE►
[Image: Tech Titans]
Meet the 43 Finalists for the 2022 Tech Titans Awards
by Dallas Innovates | Staff Report | Sep 7, 2022
Every year, Tech Titans highlights the top movers and shakers in the North Texas technology ecosystem. Here are the finalists in 11 categories. Winners will be announced at the group's signature gala in October.
MORE►
by David Seeley |
Jun 3, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from The DEC, American Airlines, Perimeter Medical, BRIX, NEC Corp. of America, Valor, Vizient, Apty, DHA Housing Solutions for North Texas, Southwest Airlines, Nanoscope Therapeutics, TimelyMD, and Thryv Holdings.
MORE►
by Dallas Innovates | Staff Report |
Oct 26, 2021
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE►
[Image: Natali_Mis/istockphoto]
Bedford Biotech Restores “Meaningful Vision” in Blind Patients With Gene Therapy—and May Soon Go Public
by David Seeley | Jun 22, 2021
Nanoscope Therapeutics successfully treated 11 patients blinded by advanced retinitis pigmentosa (RP). A single intravitreal injection produced positive results that persisted through one year. The startup plans a Phase 2b trial this summer and plans to develop gene therapies to treat more common retinal diseases—like dry age-related macular degeneration.
MORE►
by Lauren Hawkins |
Jul 21, 2020
Nanoscope Therapeutics, a TechFW client, has closed an over-subscribed Series A funding round for its leading work on retinas, which could enable the blind to see.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
